QUESTLAB

Quest Laboratories Share Price

 

 

Start SIP in QUESTLAB

Start SIP

Performance

  • Low
  • ₹102
  • High
  • ₹108
  • 52 Week Low
  • ₹75
  • 52 Week High
  • ₹160
  • Open Price₹103
  • Previous Close₹100
  • Volume51,600

Investment Returns

  • Over 1 Month + 20.56%
  • Over 3 Month + 11.27%
  • Over 6 Month + 24.07%
  • Over 1 Year -0.29%

Smart Investing Starts Here Start SIP with Quest Laboratories for Steady Growth!

Invest Now

Quest Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 12.6
  • PEG Ratio
  • -
  • Market Cap Cr
  • 172
  • P/B Ratio
  • 1.9
  • Average True Range
  • 4.96
  • EPS
  • 8.63
  • Dividend Yield
  • 0
  • MACD Signal
  • 2.56
  • RSI
  • 65.14
  • MFI
  • 87.41

Quest Laboratories Financials

Quest Laboratories Technicals

EMA & SMA

Current Price
₹104.65
+ 4.65 (4.65%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹95.21
  • 50 Day
  • ₹92.37
  • 100 Day
  • ₹93.56
  • 200 Day
  • ₹98.83

Resistance and Support

104.87 Pivot Speed
  • R3 113.68
  • R2 110.82
  • R1 107.73
  • S1 101.78
  • S2 98.92
  • S3 95.83

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Quest Laboratories Ltd has an operating revenue of Rs. 152.72 Cr. on a trailing 12-month basis. An annual revenue growth of 31% is outstanding, Pre-tax margin of 18% is great, ROE of 16% is good. The company has a reasonable debt to equity of 2%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its 200DMA and around 11% above its 50DMA. It needs to stay above the 200DMA levels to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 21% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 83 which is a GOOD score indicating consistency in earnings, a RS Rating of 64 which is FAIR indicating the recent price performance, Buyer Demand at C- which is evident from recent supply seen, Group Rank of 86 indicates it belongs to a poor industry group of Medical-Biomed/Biotech and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Quest Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-13 Quarterly Results & Others To consider other business matters.
2025-05-28 Audited Results
2025-01-27 Others To consider other business matters.
2024-11-14 Quarterly Results & Others To consider other business matters.

Quest Laboratories F&O

Quest Laboratories Shareholding Pattern

66.78%
0%
0.93%
25.5%
6.79%

About Quest Laboratories

  • NSE Symbol
  • QUESTLAB
  • BSE Symbol
  • Chairman & Managing Director
  • Mr. Anil Kumar Sabarwal
  • ISIN
  • INE0TNW01017

Similar Stocks to Quest Laboratories

Quest Laboratories FAQs

Quest Laboratories share price is ₹104 As on 30 December, 2025 | 23:57

The Market Cap of Quest Laboratories is ₹171.5 Cr As on 30 December, 2025 | 23:57

The P/E ratio of Quest Laboratories is 12.6 As on 30 December, 2025 | 23:57

The PB ratio of Quest Laboratories is 1.9 As on 30 December, 2025 | 23:57

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23